NATIXIS_REGISTRATION_DOCUMENT_2017

5 FINANCIAL DATA

Consolidated financial statements and notes

Available-for-sale financial assets 6.4 The table below shows available-for-salefinancial assets by type of instrument (loans outstanding, fixed-income securities, variable-incomesecurities). It discloses the gross value before impairment, the amount of impairment and the net value after impairment.

Available-for-salefinancialassetsare tested for impairmentat the end of each reporting period (i.e. every quarter). When there is objective evidence of impairment and a reduction in fair value has previously been recognized in equity, the aggregate impairmentloss is removedfromequityand taken to income.

12.31.2017

12.31.2016

(in millions of euros)

Loans outstanding

18 18

16 16

Loans and receivables Accrued interest Securities services

0

58,382 49,209

55,538 47,611

Fixed-income

Variable-income  (a) Accrued interest

8,625

7,363

549

564

Total available-for-sale financial assets before impairment

58,400

55,554

Impairment of available-for-sale assets

(515)

(563)

Loans and receivables Fixed-income securities

(15) (43)

(14) (36)

Variable-income securities  (b)

(458)

(513)

TOTAL  (c)

57,885

54,990

Including shares in mutual funds. (a) In 2017, permanent impairment of variable-income securities stood at €27 million compared with €58 million in 2016. This expense involves insurance portfolios for (b) €15 million (€40 million for 2016), the impact of which is neutralized at 89% and 87.0% respectively for 2017 and 2016 given the profit-sharing mechanism. The 2017 expense is divided between an additional impairment on previously-impaired securities for €18 million, including €7 million related to the insurance portfolios (€21 million in 2016, including €5 million on insurance portfolios), newly-impaired provisions on securities tied to the application of analysis criteria as defined in accounting principles

and methods for €9 million mainly related to insurance portfolios (€37 million in 2016 mainly related to insurance portfolios). Of which €44,444 million for insurance activities at December 31, 2017, and €41,048 million at December 31, 2016. (c)

Loans and receivables 6.5

6.5.1

Loans and receivables due from banks

Notes

12.31.2017

12.31.2016

(in millions of euros)

Outstanding

45,358 45,295

58,854 58,783

Performing loans

6.5.2

Non-performing loans

63

71

PROVISIONS

(69)

(71)

TOTAL NET  (a)

45,289

58,783

The fair value of loans and receivables due from banks is provided in Note 6.7.6. Of which €1,296 million for insurance activities at December 31, 2017, and €1,152 million at December 31, 2016. (a)

6.5.2

Performing loans to banks

12.31.2017

12.31.2016

(in millions of euros)

Loans and receivables

31,013

37,654

Current accounts overdrawn Unlisted fixed-income securities

6,429

8,401 1,298

296

Reverse repos Accrued interest

7,495

11,306

62

125

TOTAL

45,295

58,783

254

Natixis Registration Document 2017